X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (308) 308
Patent (61) 61
Book Review (30) 30
Conference Proceeding (11) 11
Book Chapter (9) 9
Publication (7) 7
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (174) 174
animals (145) 145
mice (135) 135
osteoclasts - cytology (77) 77
humans (72) 72
male (64) 64
cells, cultured (61) 61
endocrinology & metabolism (53) 53
osteoclasts - metabolism (53) 53
chemistry (43) 43
metallurgy (43) 43
osteoclasts - drug effects (43) 43
osteoprotegerin (42) 42
bone resorption (40) 40
differentiation (39) 39
osteoclast (38) 38
rank ligand (37) 37
cell differentiation - drug effects (34) 34
cells (33) 33
mice, inbred c57bl (33) 33
osteoblasts - metabolism (33) 33
osteoclasts (33) 33
receptor activator of nuclear factor-kappa b (33) 33
coculture techniques (32) 32
osteoblasts (32) 32
cell differentiation (31) 31
female (30) 30
osteoclasts - physiology (30) 30
in-vitro (29) 29
abridged index medicus (28) 28
osteoblasts - cytology (28) 28
colony-stimulating factor (27) 27
biochemistry & molecular biology (25) 25
osteoporosis (23) 23
bone (22) 22
bone-resorption (22) 22
cell biology (22) 22
compositions based thereon (22) 22
organic macromolecular compounds (22) 22
osteoblastic cells (22) 22
rank ligand - metabolism (22) 22
their preparation or chemical working-up (22) 22
calcitriol - pharmacology (21) 21
expression (20) 20
human necessities (20) 20
hygiene (20) 20
medical or veterinary science (20) 20
mice, knockout (20) 20
osteoblasts - drug effects (20) 20
signal transduction (20) 20
rankl (18) 18
acid phosphatase - metabolism (17) 17
bone marrow cells (17) 17
bone marrow cells - cytology (17) 17
bone resorption - metabolism (17) 17
differentiation factor (17) 17
ligand (17) 17
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (17) 17
osteoblast (17) 17
peptides (17) 17
preparations for medical, dental, or toilet purposes (17) 17
resorption (17) 17
stromal cells (17) 17
cell differentiation - physiology (16) 16
osteoclasts - pathology (16) 16
biochemistry (15) 15
medicine, research & experimental (15) 15
osteoblasts - physiology (15) 15
osteogenesis - drug effects (15) 15
performing operations (15) 15
research (15) 15
transporting (15) 15
immunology (14) 14
mouse (14) 14
osteoclast differentiation (14) 14
receptor (14) 14
animals, newborn (13) 13
bone resorption - pathology (13) 13
bones (13) 13
culture media (13) 13
mice, transgenic (13) 13
receptors, tumor necrosis factor (13) 13
specific therapeutic activity of chemical compounds ormedicinal preparations (13) 13
base sequence (12) 12
bone and bones - metabolism (12) 12
bone resorption - physiopathology (12) 12
carrier proteins - metabolism (12) 12
dentistry (12) 12
gene expression (12) 12
membrane glycoproteins - pharmacology (12) 12
membrane glycoproteins - physiology (12) 12
middle aged (12) 12
musculoskeletal diseases (12) 12
necrosis-factor receptor (12) 12
oncology (12) 12
tartrate-resistant acid phosphatase (12) 12
actins - metabolism (11) 11
cell differentiation - genetics (11) 11
cell line (11) 11
ligands (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical calcium, ISSN 0917-5857, 2018, Volume 28, Issue 1, p. 104
This is a brief report summarizing topics in ASBMR 2017 held at Colorado Convention Center in Denver on September 8-11th. In this paper, I report some topics... 
Bone Resorption | Congresses as Topic | Animals | Societies, Medical | Bone and Bones - metabolism | Humans | Cell Differentiation | Osteoclasts - cytology | Osteoclasts - metabolism
Journal Article
Clinical calcium, ISSN 0917-5857, 2017, Volume 27, Issue 1, p. 128
This is a brief report summarizing topics in ASBMR 2016 held at Georgia World Congress Center in Atlanta on September 16-19th. In this paper, I report some... 
Journal Article
Clinical calcium, ISSN 0917-5857, 01/2016, Volume 26, Issue 1, pp. 128 - 132
Journal Article
Clinical calcium, ISSN 0917-5857, 01/2016, Volume 26, Issue 1, p. 128
This is a brief report summarizing topics in ASBMR 2015 held at Washington State Convention Center in Seattle on October 9-12th. In this paper, I report some... 
Societies, Medical - organization & administration | Bone Resorption | Animals | United States | Humans | Societies, Scientific - organization & administration | Osteoclasts | Societies, Dental - organization & administration
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/1998, Volume 95, Issue 7, pp. 3597 - 3602
Journal Article
Nature Medicine, ISSN 1078-8956, 03/2012, Volume 18, Issue 3, pp. 405 - 412
The signaling molecule Wnt regulates bone homeostasis through beta-catenin-dependent canonical and beta-catenin-independent noncanonical pathways. Impairment... 
RHEUMATOID-ARTHRITIS | MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | RECESSIVE ROBINOW-SYNDROME | CELL BIOLOGY | BONE-FORMATION | PATHWAY | DIFFERENTIATION | ROR2 | C-JUN | WNT | EXPRESSION | RECEPTOR TYROSINE KINASE | Arthritis - metabolism | Wnt Proteins - deficiency | Bone Diseases - metabolism | Wnt-5a Protein | Osteoclasts - cytology | Wnt Proteins - metabolism | X-Ray Microtomography | MAP Kinase Kinase 4 - metabolism | Wnt Proteins - genetics | Osteoblasts - cytology | Receptor Activator of Nuclear Factor-kappa B - metabolism | Wnt Signaling Pathway | Promoter Regions, Genetic | Proto-Oncogene Proteins c-jun - genetics | Receptor Tyrosine Kinase-like Orphan Receptors - metabolism | Gene Expression Regulation | Receptor Tyrosine Kinase-like Orphan Receptors - deficiency | Osteoclasts - metabolism | Cell Lineage | Animals | Proto-Oncogene Proteins c-jun - metabolism | Skull - cytology | Receptor Activator of Nuclear Factor-kappa B - genetics | Receptor Tyrosine Kinase-like Orphan Receptors - genetics | Mice | Osteoblasts - metabolism | Skull - growth & development | Osteoporosis | Care and treatment | Physiological aspects | Cellular signal transduction | Genetic aspects | Research | Osteoclasts (Biology) | Proteins | Signal transduction | Bone density | Cellular biology | Gene expression | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 09/2018, Volume 561, Issue 7722, pp. 195 - 200
Journal Article
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 2012, Volume 14, Issue Suppl 1, pp. O26 - O26
Conference Proceeding
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, pp. e0184904 - e0184904
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2017, Volume 32, Issue 10, pp. 2074 - 2086
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2017, Volume 32, Issue 6, pp. 1297 - 1308
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, pp. e0181126 - e0181126
The Janus kinases (Jaks) are hubs in the signaling process of more than 50 cytokine or hormone receptors. However, the function of Jak in bone metabolism... 
TRABECULAR BONE | CELLS | CYTOKINES | BONE-FORMATION | SIGNALING PATHWAY | MULTIDISCIPLINARY SCIENCES | RECEPTOR | DIFFERENTIATION | KNOCKOUT MICE | ARTHRITIS | INTERLEUKIN-6 | RANK Ligand - metabolism | Coculture Techniques | Male | Azetidines - pharmacology | Recombinant Proteins - biosynthesis | Recombinant Proteins - isolation & purification | Janus Kinase 1 - metabolism | RANK Ligand - pharmacology | RNA Interference | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Bone Marrow Cells - drug effects | Interleukin-11 - secretion | Osteoblasts - cytology | Interleukin-6 - metabolism | Janus Kinase 2 - antagonists & inhibitors | Cell Survival - drug effects | Dinoprostone - pharmacology | Bone Marrow Cells - cytology | Osteoblasts - drug effects | Osteogenesis - drug effects | Janus Kinase 2 - genetics | Interleukin-11 - metabolism | Macrophage Colony-Stimulating Factor - metabolism | Recombinant Proteins - pharmacology | Down-Regulation - drug effects | Janus Kinase 1 - antagonists & inhibitors | Sulfonamides - pharmacology | Interleukin-6 - secretion | RANK Ligand - genetics | Animals | Cell Differentiation - drug effects | Mice | Osteoblasts - metabolism | Bone Marrow Cells - metabolism | Cholecalciferol - pharmacology | Enzymes | Cellular signal transduction | Genetic aspects | Regulation | Gene expression | Phosphotransferases | Health aspects | Cell culture | Leukemia | Interleukin | Calcitriol | Arthritis | Biochemistry | Bone diseases | Kinases | Macrophages | Osteoblasts | Bone surgery | Interleukin 6 | Osteoporosis | Signal transduction | Receptors | Biomedical materials | Dihydroxyvitamin D3 | Janus kinase 2 | Bone marrow | Janus kinase | Biocompatibility | Colony-stimulating factor | Inhibition | Recombinant | Cytokines | Secretion | Leukemia inhibitory factor | Macrophage colony-stimulating factor | Interleukin 11 | Bone turnover | Metabolism | Osteoclastogenesis | Calvaria | Osteoblastogenesis | Inhibitors | Rheumatoid arthritis | Orthopedics | Osteoclasts | Receptor mechanisms | Differentiation | In vitro methods and tests | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2007, Volume 108, Issue 1, pp. 226 - 233
Abstract Objective. To establish an optimal adjuvant therapy for intermediate- and high-risk endometrial cancer patients, we conducted a multi-center... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Adjuvant radiotherapy | Adjuvant chemotherapy | Endometrial cancer | Cisplatin-based chemotherapy | Intermediate risk | SURGERY | adjuvant chemotherapy | intermediate risk | CLINICAL STAGE-I | ADENOCARCINOMA | DOXORUBICIN | OBSTETRICS & GYNECOLOGY | POSTOPERATIVE RADIATION | IRRADIATION | THERAPY | MODELS | ONCOLOGY | endometrial cancer | cisplatin-based chemotherapy | adjuvant radiotherapy | CARCINOMA | Endometrial Neoplasms - radiotherapy | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Adenocarcinoma - radiotherapy | Doxorubicin - administration & dosage | Risk Factors | Treatment Outcome | Adenocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - surgery | Cisplatin - adverse effects | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Patient Compliance | Neoplasm Staging | Doxorubicin - adverse effects | Adenocarcinoma - surgery | Care and treatment | Chemotherapy | Oncology, Experimental | Clinical trials | Research | Radiotherapy | Cancer | Index Medicus
Journal Article